Pharma Deals
Merger and Acquisition Transactions in Pharma, Licensing Deals,
Pages
(Move to ...)
Home
Global Pharma Intelligence
Japan Pharma Intelligence
Clinical Trial Data
Health News
Investment Ideas
New Drug Approvals
▼
Wednesday, 18 September 2013
Servier in licensing pact with SIMM for the development in China of lucitanib
›
Servier has signed an agreement with the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, (SIMM) for the development i...
Monday, 16 September 2013
Azaya therapeutics outlicenses rights to liposomal docetaxel (AT1123) to Beijing’s CANbridge Lifescience
›
CANbridge Life Sciences, a Beijing in-licensing firm, has secured the China rights to a cancer drug from Azaya Therapeutics of San Anto...
Wednesday, 11 September 2013
AstraZeneca and Merck & Co Inc enter into worldwide licensing agreement for Merck's oral small molecule inhibitor of WEE1 kinase (MK-1775)
›
AstraZeneca and Merck & Co Inc , known outside the United States and Canada as MSD, today announced a worldwide licensing agreement ...
Tuesday, 10 September 2013
Eddingpharm inlicenses China rights to Entinostat from Syndax Pharma
›
Syndax Pharmaceuticals Inc., which is developing epigenetic therapies for treatment-resistant cancers and Eddingpharm, a leading specialt...
Monday, 9 September 2013
Otsuka to acquire Astex Pharmaceuticals for $886m
›
Otsuka Holdings will buy Astex for a total of around $886m at $8.50/share, a 27% premium to the 3 September closing price. The acquisitio...
19 comments:
›
Home
View web version